Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

SIMPLE SUMMARY: Therapies for squamous cell carcinomas of the head and neck (SCCHN) have been rapidly evolving, initially with the inclusion of immunotherapy, but more recently with the consideration of anti-angiogenic therapies. Recent preclinical and clinical data reveal a strong correlation betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Nabil F., Vijayvargiya, Pooja, Vermorken, Jan B., Rodrigo, Juan P., Willems, Stefan M., Zidar, Nina, de Bree, Remco, Mäkitie, Antti, Wolf, Greg T., Argiris, Athanassios, Teng, Yong, Ferlito, Alfio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909398/
https://www.ncbi.nlm.nih.gov/pubmed/35267508
http://dx.doi.org/10.3390/cancers14051202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909398/
https://www.ncbi.nlm.nih.gov/pubmed/35267508
http://dx.doi.org/10.3390/cancers14051202

Ejemplares similares